The DOI matches its Crossref record.
Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis: REVIEW OF A 25-YEAR EXPERIENCE WITH 68 CASES
Abstract
This paper reports the experiences of our group with 68 patients with progressive systemic sclerosis (PSS) admitted to hospitals of the University of Pittsburgh Health Center between 1955 and 1981 with scleroderma renal crisis (SRC). The onset of SRC was characterized by four features, namely, onset or aggravation, usually abrupt, of arterial hypertension; appearance of Grade III or IV retinopathy; elevations of peripheral renin activity to at least twice the upper limit of normal; and rapid deterioration of renal function within a period of less than one month. Over 90% of our patients in whom these criteria could be determined had at least three of them present with the onset of SRC. Management of these patients during the first 15 years of this period was uniformly ineffective. Before 1971, no patients lived longer than a year; usual survival ranged from 1 to 3 months. With the advent of renal dialysis and the more effective treatment of severe hypertension, along with the utilization of bilateral nephrectomy in selected anuric patients, some improvement in longevity was achieved. However, only in the past few years have we accumulated a group of 11 patients who have survived for longer than one year. The clinical characteristics of the onset and progression of SRC suggest the sudden imposition of severe stress such as cold or an autoimmune insult affecting vulnerable arteries and arterioles. The renal damage becomes self-perpetuating with extremely high renin activity causing further rise in blood pressure and additional renal and systemic vascular damage. Progress in the last few years seems to have been achieved primarily by the advent of pharmacologic agents that specifically block the effect of angiotensin II by inhibiting the angiotensin I converting enzyme. When diagnosis is prompt and the condition is treated as an emergency with these compounds, we and others have found that normal renal function can be restored in a number of patients. The result is a considerably brighter outlook for patients with this previously rapidly fatal complication of progressive systemic sclerosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Steen, V. D., Costantino, J. P., Shapiro, A. P., & Medsger, T. A. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-5-352 · Cited by 441
Self-citationScleroderma renal crisis: patient characteristics and long-term outcomes
Penn, H., Howie, A. J., Kingdon, E. J., Bunn, C. C., Stratton, R. J., Black, C. M., Burns, A., & Denton, C. P. (2007) · QJM · doi:10.1093/qjmed/hcm052 · Cited by 427
Pulmonary hypertension in the crest syndrome variant of systemic sclerosis
Stupi, A. M., Steen, V. D., Owens, G. R., Barnes, E. L., Rodnan, G. P., & Medsger, T. A. (1986) · Arthritis & Rheumatism · doi:10.1002/art.1780290409 · Cited by 367
Self-citationOn Scleroderma: Mast Cells, Endothelial Cells, and Fibroblasts
Claman, H. N. (1989) · JAMA · doi:10.1001/jama.1989.03430090068035 · Cited by 112
Metadata
- Authors
- TRAUB, Y. M., SHAPIRO, A. P., RODNAN, G. P., MEDSGER, T. A., MCDONALD, R. H., STEEN, V. D., OSIAL, T. A., & TOLCHIN, S. F.
- Venue
- Medicine
- Published
- 1983-11
- Volume
- 62
- Issue
- 6
- Pages
- 335-352
- ISSN
- 0025-7974 (ISSN-L)
- OpenAlex
- W2040990606
- Cited by
- 237
- References
- 0
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis: REVIEW OF A 25-YEAR EXPERIENCE WITH 68 CASES. https://app.cochat.ai/papers/10.1097/00005792-198311000-00001
- The paper
- TRAUB, Y. M., SHAPIRO, A. P., RODNAN, G. P., MEDSGER, T. A., MCDONALD, R. H., STEEN, V. D., OSIAL, T. A., & TOLCHIN, S. F. (1983). Hypertension and Renal Failure (Scleroderma Renal Crisis) in Progressive Systemic Sclerosis: REVIEW OF A 25-YEAR EXPERIENCE WITH 68 CASES. Medicine. https://doi.org/10.1097/00005792-198311000-00001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.